It’s been a week since #GivingTuesday 2017 and we’re still overwhelmed by the incredible participation of companies and people around the world who, together, raised a staggering $264.6 million in the movement's sixth year. At Benevity, almost 200 of our enterprise clients got involved, with their employees logging 45,000 volunteer hours and donating $13 million (including employer matching) to nearly 11,000 charities around the world.
With one of the most diverse boards in the technology industry, HP understands the value and importance of supporting broad age, gender, ethnic and cultural diversity across company and nonprofit board members. HP is proud to be both a sponsor of, and contributor to, this Better World Leadership Nonprofit Board Study, to help drive greater awareness of the board service as a catalyst for increasing diversity and inclusion, human capital development, and economic development.
When I was a high school student, I took a serious interest in biology and chemistry, and I always asked my teachers: "But how did they find that out?" This was my first approach to scientific discovery and, from there on, I made the decision to get a science-related degree. Upon my entry to university, I started to work on basic science research projects, however I realized that I wanted to do research that would have an actual impact in human health and disease.
When Cameron Clarke was first assigned a policy brief as an Amgen Scholar at the National Institutes of Health (NIH) in 2016, it was the start of something big: a career in public health policy. In the year that followed, he would use the policy brief writing skills again and again as an intern on Capitol Hill, and then with several local government organizations on issues ranging from opioid addiction and minority health inequities to environmental policy. Now a Rhodes Scholar at Oxford, Clarke’s work focuses on systematically reviewing research to translate the results into policy recommendations.